CAG-Repeat Length and the Age of Onset in Huntington Disease (HD): A Review and Validation Study of Statistical Approaches

被引:257
作者
Langbehn, Douglas R. [1 ,2 ]
Hayden, Michael R. [3 ]
Paulsen, Jane S. [1 ,4 ]
机构
[1] Univ Iowa, Carver Coll Med, Dept Psychiat Res, Iowa City, IA 52242 USA
[2] Univ Iowa, Sch Publ Hlth, Dept Biostat, Iowa City, IA 52242 USA
[3] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada
[4] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
Huntington disease; polyglutamine expansion; survival analysis; prognosis; TRINUCLEOTIDE REPEAT; CLINICAL-FEATURES; INSTABILITY; DIAGNOSIS; FAMILY;
D O I
10.1002/ajmg.b.30992
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
CAG-repeat length in the gene for HD is inversely correlated with age of onset (AOO). A number of statistical models elucidating the relationship between CAG length and AOO have recently been published. In the present article, we review the published formulae, summarize essential differences in participant sources, statistical methodologies, and predictive results. We argue that unrepresentative sampling and failure to use appropriate survival analysis methodology may have substantially biased much of the literature. We also explain why the survival analysis perspective is necessary if any such model is to undergo prospective validation. We use prospective diagnostic data from the PREDICT-HD longitudinal study of CAG-expanded participants to test conditional predictions derived from two survival models of AOO of HD. A prior model of the relationship of CAG and AOO originally published by Langbehn et al. yields reasonably accurate predictions, while a similar model by Gutierrez and MacDonald substantially overestimates diagnosis risk for all but the highest risk participants in this sample. The Langbehn et al. model appears accurate enough to have substantial utility in various research contexts. We also emphasize remaining caveats, many of which are relevant for any direct application to genetic counseling. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:397 / 408
页数:12
相关论文
共 52 条
[11]  
[Anonymous], 1996, Survival analysis with long-term survivors
[12]   Basal ganglia volume and proximity to onset in presymptomatic Huntington disease [J].
Aylward, EH ;
Codori, AM ;
Barta, PE ;
Pearlson, GD ;
Harris, GJ ;
Brandt, J .
ARCHIVES OF NEUROLOGY, 1996, 53 (12) :1293-1296
[13]  
Brinkman RR, 1997, AM J HUM GENET, V60, P1202
[14]  
Burnham K.P., 1998, MODEL SELECTION INFE
[15]   Transcriptional signatures in Huntington's disease [J].
Cha, Jang-Ho J. .
PROGRESS IN NEUROBIOLOGY, 2007, 83 (04) :228-248
[16]   Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type 2 patients originated from eastern India [J].
Chattopadhyay, B ;
Ghosh, S ;
Gangopadhyay, PK ;
Das, SK ;
Roy, T ;
Sinha, KK ;
Jha, DK ;
Mukherjee, SC ;
Chakraborty, A ;
Singhal, BS ;
Bhattacharya, AK ;
Bhattacharyya, NP .
NEUROSCIENCE LETTERS, 2003, 345 (02) :93-96
[17]   Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease [J].
Djoussé, L ;
Knowlton, B ;
Hayden, M ;
Almqvist, EW ;
Brinkman, R ;
Ross, C ;
Margolis, R ;
Rosenblatt, A ;
Durr, A ;
Dode, C ;
Morrison, PJ ;
Novelletto, A ;
Frontali, M ;
Trent, RJA ;
McCusker, E ;
Gómez-Tortosa, E ;
Mayo, D ;
Jones, R ;
Zanko, A ;
Nance, M ;
Abramson, R ;
Suchowersky, O ;
Paulsen, J ;
Harrison, M ;
Yang, Q ;
Cupples, LA ;
Gusella, JF ;
MacDonald, ME ;
Myers, RH .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 119A (03) :279-282
[18]   TRINUCLEOTIDE REPEAT LENGTH INSTABILITY AND AGE-OF-ONSET IN HUNTINGTONS-DISEASE [J].
DUYAO, M ;
AMBROSE, C ;
MYERS, R ;
NOVELLETTO, A ;
PERSICHETTI, F ;
FRONTALI, M ;
FOLSTEIN, S ;
ROSS, C ;
FRANZ, M ;
ABBOTT, M ;
GRAY, J ;
CONNEALLY, P ;
YOUNG, A ;
PENNEY, J ;
HOLLINGSWORTH, Z ;
SHOULSON, I ;
LAZZARINI, A ;
FALEK, A ;
KOROSHETZ, W ;
SAX, D ;
BIRD, E ;
VONSATTEL, J ;
BONILLA, E ;
ALVIR, J ;
CONDE, JB ;
CHA, JH ;
DURE, L ;
GOMEZ, F ;
RAMOS, M ;
SANCHEZRAMOS, J ;
SNODGRASS, S ;
DEYOUNG, M ;
WEXLER, N ;
MOSCOWITZ, C ;
PENCHASZADEH, G ;
MACFARLANE, H ;
ANDERSON, M ;
JENKINS, B ;
SRINIDHI, J ;
BARNES, G ;
GUSELLA, J ;
MACDONALD, M .
NATURE GENETICS, 1993, 4 (04) :387-392
[19]   Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases [J].
Falush, D ;
Almqvist, EW ;
Brinkmann, RR ;
Iwasa, Y ;
Hayden, MR .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (02) :373-385
[20]  
Gutierrez C., 2004, Scandinavian Actuarial Journal, V4, P279, DOI DOI 10.1080/